Annual Gross Profit
$220.10 M
+$32.04 M+17.04%
December 31, 2023
Summary
- As of February 7, 2025, PHAR annual gross profit is $220.10 million, with the most recent change of +$32.04 million (+17.04%) on December 31, 2023.
- During the last 3 years, PHAR annual gross profit has risen by +$31.47 million (+16.68%).
- PHAR annual gross profit is now at all-time high.
Performance
PHAR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$68.03 M
+$1.92 M+2.90%
September 30, 2024
Summary
- As of February 7, 2025, PHAR quarterly gross profit is $68.03 million, with the most recent change of +$1.92 million (+2.90%) on September 30, 2024.
- Over the past year, PHAR quarterly gross profit has increased by +$20.83 million (+44.13%).
- PHAR quarterly gross profit is now -8.19% below its all-time high of $74.10 million, reached on December 31, 2023.
Performance
PHAR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$255.44 M
+$9.66 M+3.93%
September 30, 2024
Summary
- As of February 7, 2025, PHAR TTM gross profit is $255.44 million, with the most recent change of +$9.66 million (+3.93%) on September 30, 2024.
- Over the past year, PHAR TTM gross profit has increased by +$26.60 million (+11.63%).
- PHAR TTM gross profit is now at all-time high.
Performance
PHAR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
PHAR Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.0% | +44.1% | +11.6% |
| 3 y3 years | +16.7% | +44.4% | +43.7% |
| 5 y5 years | +70.3% | +65.9% | +35.0% |
PHAR Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.8% | -8.2% | +76.9% | at high | +43.7% |
| 5 y | 5-year | at high | +33.0% | -8.2% | +76.9% | at high | +54.4% |
| alltime | all time | at high | +1024.8% | -8.2% | +3127.5% | at high | +9910.3% |
Pharming Group NV Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $68.03 M(+2.9%) | $255.44 M(+3.9%) |
| Jun 2024 | - | $66.11 M(+40.1%) | $245.78 M(+7.4%) |
| Mar 2024 | - | $47.20 M(-36.3%) | $228.84 M(+4.0%) |
| Dec 2023 | $220.10 M(+17.0%) | $74.10 M(+27.0%) | $220.10 M(+13.2%) |
| Sep 2023 | - | $58.37 M(+18.7%) | $194.35 M(+3.5%) |
| Jun 2023 | - | $49.17 M(+27.8%) | $187.84 M(+1.7%) |
| Mar 2023 | - | $38.47 M(-20.4%) | $184.79 M(-1.7%) |
| Dec 2022 | $188.06 M(+5.8%) | $48.35 M(-6.8%) | $188.06 M(+0.7%) |
| Sep 2022 | - | $51.85 M(+12.4%) | $186.84 M(+2.8%) |
| Jun 2022 | - | $46.12 M(+10.5%) | $181.84 M(+0.6%) |
| Mar 2022 | - | $41.74 M(-11.4%) | $180.75 M(+1.7%) |
| Dec 2021 | $177.73 M(-5.8%) | $47.13 M(+0.6%) | $177.73 M(-0.3%) |
| Sep 2021 | - | $46.85 M(+4.0%) | $178.33 M(-3.0%) |
| Jun 2021 | - | $45.03 M(+16.3%) | $183.83 M(+2.7%) |
| Mar 2021 | - | $38.72 M(-18.9%) | $178.93 M(-5.1%) |
| Dec 2020 | $188.63 M(+14.0%) | $47.73 M(-8.9%) | $188.63 M(-0.3%) |
| Sep 2020 | - | $52.36 M(+30.5%) | $189.21 M(+6.4%) |
| Jun 2020 | - | $40.13 M(-17.1%) | $177.86 M(-1.4%) |
| Mar 2020 | - | $48.42 M(+0.2%) | $180.41 M(+9.0%) |
| Dec 2019 | $165.46 M(+28.1%) | $48.30 M(+17.8%) | $165.46 M(+9.9%) |
| Sep 2019 | - | $41.00 M(-3.9%) | $150.57 M(+2.0%) |
| Jun 2019 | - | $42.68 M(+27.5%) | $147.57 M(+11.4%) |
| Mar 2019 | - | $33.47 M(+0.2%) | $132.52 M(+2.6%) |
| Dec 2018 | $129.20 M(+39.5%) | $33.41 M(-12.1%) | $129.20 M(-1.4%) |
| Sep 2018 | - | $38.00 M(+37.5%) | $131.07 M(+9.7%) |
| Jun 2018 | - | $27.63 M(-8.4%) | $119.50 M(+10.6%) |
| Mar 2018 | - | $30.16 M(-14.5%) | $108.04 M(+16.7%) |
| Dec 2017 | $92.59 M | $35.28 M(+33.4%) | $92.59 M(+47.1%) |
| Sep 2017 | - | $26.44 M(+63.5%) | $62.95 M(+61.4%) |
| Jun 2017 | - | $16.17 M(+9.9%) | $39.00 M(+57.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $14.71 M(+160.6%) | $24.71 M(+110.0%) |
| Dec 2016 | $11.77 M(+78.6%) | $5.64 M(+126.9%) | $11.77 M(+59.7%) |
| Sep 2016 | - | $2.49 M(+32.8%) | $7.37 M(+5.4%) |
| Jun 2016 | - | $1.87 M(+6.1%) | $6.99 M(-6.9%) |
| Mar 2016 | - | $1.76 M(+41.9%) | $7.51 M(+14.0%) |
| Dec 2015 | $6.59 M(-69.5%) | $1.24 M(-41.1%) | $6.59 M(-74.1%) |
| Sep 2015 | - | $2.11 M(-11.7%) | $25.44 M(+6.8%) |
| Jun 2015 | - | $2.39 M(+183.9%) | $23.82 M(+7.5%) |
| Mar 2015 | - | $842.50 K(-95.8%) | $22.16 M(+2.6%) |
| Dec 2014 | $21.60 M(+172.8%) | $20.10 M(+4009.2%) | $21.60 M(+1021.2%) |
| Sep 2014 | - | $489.10 K(-33.0%) | $1.93 M(-24.2%) |
| Jun 2014 | - | $730.40 K(+162.9%) | $2.54 M(-66.4%) |
| Mar 2014 | - | $277.80 K(-35.2%) | $7.57 M(-4.3%) |
| Dec 2013 | $7.92 M(-5.7%) | $428.70 K(-61.2%) | $7.92 M(-53.7%) |
| Sep 2013 | - | $1.11 M(-80.8%) | $17.11 M(+4.5%) |
| Jun 2013 | - | $5.76 M(+829.6%) | $16.38 M(+95.7%) |
| Mar 2013 | - | $619.80 K(-93.6%) | $8.37 M(-0.3%) |
| Dec 2012 | $8.39 M(-1319.5%) | $9.63 M(+2518.8%) | $8.39 M(-585.0%) |
| Sep 2012 | - | $367.60 K(-116.4%) | -$1.73 M(-33.5%) |
| Jun 2012 | - | -$2.25 M(-448.0%) | -$2.60 M(+237.1%) |
| Mar 2012 | - | $645.70 K(-230.0%) | -$772.50 K(+12.2%) |
| Dec 2011 | -$688.20 K(-207.6%) | -$496.70 K(-1.8%) | -$688.20 K(-279.1%) |
| Sep 2011 | - | -$505.70 K(+21.6%) | $384.20 K(-56.8%) |
| Jun 2011 | - | -$415.80 K(-157.0%) | $889.90 K(-31.8%) |
| Mar 2011 | - | $730.00 K(+26.8%) | $1.31 M(+126.8%) |
| Dec 2010 | $639.70 K(+33.3%) | $575.70 K(>+9900.0%) | $575.70 K(>+9900.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2010 | - | $0.00 | $0.00 |
| Dec 2009 | $480.00 K(-102.0%) | - | - |
| Dec 2006 | -$23.80 M | - | - |
FAQ
- What is Pharming Group NV annual gross profit?
- What is the all time high annual gross profit for Pharming Group NV?
- What is Pharming Group NV annual gross profit year-on-year change?
- What is Pharming Group NV quarterly gross profit?
- What is the all time high quarterly gross profit for Pharming Group NV?
- What is Pharming Group NV quarterly gross profit year-on-year change?
- What is Pharming Group NV TTM gross profit?
- What is the all time high TTM gross profit for Pharming Group NV?
- What is Pharming Group NV TTM gross profit year-on-year change?
What is Pharming Group NV annual gross profit?
The current annual gross profit of PHAR is $220.10 M
What is the all time high annual gross profit for Pharming Group NV?
Pharming Group NV all-time high annual gross profit is $220.10 M
What is Pharming Group NV annual gross profit year-on-year change?
Over the past year, PHAR annual gross profit has changed by +$32.04 M (+17.04%)
What is Pharming Group NV quarterly gross profit?
The current quarterly gross profit of PHAR is $68.03 M
What is the all time high quarterly gross profit for Pharming Group NV?
Pharming Group NV all-time high quarterly gross profit is $74.10 M
What is Pharming Group NV quarterly gross profit year-on-year change?
Over the past year, PHAR quarterly gross profit has changed by +$20.83 M (+44.13%)
What is Pharming Group NV TTM gross profit?
The current TTM gross profit of PHAR is $255.44 M
What is the all time high TTM gross profit for Pharming Group NV?
Pharming Group NV all-time high TTM gross profit is $255.44 M
What is Pharming Group NV TTM gross profit year-on-year change?
Over the past year, PHAR TTM gross profit has changed by +$26.60 M (+11.63%)